Fasting Insulin and Risk of Overall and 14 Site-Specific Cancers: Evidence From Genetic Data (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2022.863340
PubMed Identifier: 35530326
Publication URI: http://europepmc.org/abstract/MED/35530326
Type: Journal Article/Review
Parent Publication: Frontiers in Oncology
ISSN: 2234-943X